CLDX — Celldex Therapeutics, Inc. stock price, charts and financials

QT53Celldex Therapeutics, Inc.

Celldex Therapeutics, Inc. (NASDAQ: CLDX) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
39.05
+1.36+3.61%
OverviewShort InterestFilings
CLDXQT53Celldex Therapeutics, Inc.·NASDAQ
39.05+3.61%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Jul 15, 20268-KCurrent report
Jun 29, 20264Statement of changes in beneficial ownership
Jun 29, 20264Statement of changes in beneficial ownership
Jun 29, 20264Statement of changes in beneficial ownership
Jun 29, 20264Statement of changes in beneficial ownership
Jun 29, 20264Statement of changes in beneficial ownership
Jun 29, 20264Statement of changes in beneficial ownership
Jun 29, 20264Statement of changes in beneficial ownership
Jun 29, 20264Statement of changes in beneficial ownership
Jun 29, 20264Statement of changes in beneficial ownership
Jun 29, 20264Statement of changes in beneficial ownership
Jun 29, 20264Statement of changes in beneficial ownership
Jun 29, 20264Statement of changes in beneficial ownership
Jun 29, 20264Statement of changes in beneficial ownership
Jun 29, 20264Statement of changes in beneficial ownership
Jun 29, 20264Statement of changes in beneficial ownership
Jun 29, 20264Statement of changes in beneficial ownership
Jun 29, 20264Statement of changes in beneficial ownership
Jun 29, 20264Statement of changes in beneficial ownership
Jun 26, 20268-KCurrent report
Jun 26, 2026S-8Registration of employee benefit securities
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 12, 2026SC 13GBeneficial ownership statement (passive)
May 07, 20268-KCurrent report
#1 / 25 of 291
Page
▼
/ 12